Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $221000.0.

  • Catheter Precision's Net Cash Flow fell 8234.82% to $221000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$238000.0, marking a year-over-year increase of 9447.92%. This contributed to the annual value of -$721000.0 for FY2024, which is 9413.54% up from last year.
  • Latest data reveals that Catheter Precision reported Net Cash Flow of $221000.0 as of Q3 2025, which was down 8234.82% from $388000.0 recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's Net Cash Flow ranged from a high of $4.3 million in Q2 2021 and a low of -$8.0 million during Q1 2021
  • Over the past 5 years, Catheter Precision's median Net Cash Flow value was -$1.5 million (recorded in 2024), while the average stood at -$1.2 million.
  • Per our database at Business Quant, Catheter Precision's Net Cash Flow plummeted by 30638.46% in 2021 and then surged by 53863.64% in 2022.
  • Quarter analysis of 5 years shows Catheter Precision's Net Cash Flow stood at -$5.6 million in 2021, then surged by 138.95% to $2.2 million in 2022, then crashed by 192.81% to -$2.0 million in 2023, then skyrocketed by 178.25% to $1.6 million in 2024, then crashed by 85.98% to $221000.0 in 2025.
  • Its last three reported values are $221000.0 in Q3 2025, $388000.0 for Q2 2025, and -$2.4 million during Q1 2025.